These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15343516)

  • 21. Coexpression of IGF-1R and c-Src proteins in human pancreatic ductal adenocarcinoma.
    Hakam A; Fang Q; Karl R; Coppola D
    Dig Dis Sci; 2003 Oct; 48(10):1972-8. PubMed ID: 14627343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of centromere protein H is associated with progression of renal cell carcinoma.
    Wu X; Lin Y; Shi L; Huang Y; Lai C; Wang Y; Zhang M; Wang S; Heng B; Yu G; Du X; Fang L; Fu Y; Chen J; Guo Z; Su Z; Wu S
    J Mol Histol; 2015 Oct; 46(4-5):377-85. PubMed ID: 26248586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
    Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
    Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anillin expression is a marker of favourable prognosis in patients with renal cell carcinoma.
    Ronkainen H; Hirvikoski P; Kauppila S; Vaarala MH
    Oncol Rep; 2011 Jan; 25(1):129-33. PubMed ID: 21109967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MCM - 2 and Ki - 67 as proliferation markers in renal cell carcinoma: A quantitative and semi - quantitative analysis.
    Mehdi MZ; Nagi AH; Naseem N
    Int Braz J Urol; 2016; 42(6):1121-1128. PubMed ID: 27532114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system.
    Montironi R; Santinelli A; Pomante R; Mazzucchelli R; Colanzi P; Filho AL; Scarpelli M
    Virchows Arch; 2000 Jul; 437(1):82-9. PubMed ID: 10963384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathologic T1 clear cell renal cell carcinoma: insulin-like growth factor-I receptor expression and disease-specific survival.
    Parker AS; Cheville JC; Blute ML; Igel T; Lohse CM; Cerhan JR
    Cancer; 2004 Jun; 100(12):2577-82. PubMed ID: 15197799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinoma.
    Finley DS; Shuch B; Said JW; Galliano G; Jeffries RA; Afifi AA; Castor B; Magyar C; Sadaat A; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Urol; 2011 Dec; 186(6):2168-74. PubMed ID: 22014797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma.
    Serrano MF; Katz M; Yan Y; Kibel AS; Humphrey PA
    Cancer; 2008 Aug; 113(3):477-83. PubMed ID: 18484589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MUC1 expression is correlated with nuclear grade and tumor progression in pT1 renal clear cell carcinoma.
    Leroy X; Zerimech F; Zini L; Copin MC; Buisine MP; Gosselin B; Aubert JP; Porchet N
    Am J Clin Pathol; 2002 Jul; 118(1):47-51. PubMed ID: 12109855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma.
    Ficarra V; Martignoni G; Maffei N; Brunelli M; Novara G; Zanolla L; Pea M; Artibani W
    Cancer; 2005 Jan; 103(1):68-75. PubMed ID: 15573369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinoma.
    Minardi D; Santoni M; Lucarini G; Mazzucchelli R; Burattini L; Conti A; Bianconi M; Scartozzi M; Milanese G; Primio RD; Montironi R; Cascinu S; Muzzonigro G
    Urol Oncol; 2015 Mar; 33(3):113.e1-7. PubMed ID: 25069421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.
    Delahunt B; Sika-Paotonu D; Bethwaite PB; William Jordan T; Magi-Galluzzi C; Zhou M; Samaratunga H; Srigley JR
    Am J Surg Pathol; 2011 Aug; 35(8):1134-9. PubMed ID: 21716085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biologic significance of fascin expression in clear cell renal cell carcinoma: systematic analysis of primary and metastatic tumor tissues using a tissue microarray technique.
    Zigeuner R; Droschl N; Tauber V; Rehak P; Langner C
    Urology; 2006 Sep; 68(3):518-22. PubMed ID: 16979727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of CD138 (Syndecan-1) in renal cell carcinoma is reduced with increasing nuclear grade.
    Gökden N; Greene GF; Bayer-Garner IB; Spencer HJ; Sanderson RD; Gökden M
    Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):173-7. PubMed ID: 16785785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of extensive necrosis in renal cell carcinoma.
    Collins J; Epstein JI
    Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma.
    Rogenhofer S; Kahl P; Mertens C; Hauser S; Hartmann W; Büttner R; Müller SC; von Ruecker A; Ellinger J
    BJU Int; 2012 Feb; 109(3):459-65. PubMed ID: 21810159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between CT perfusion parameters and Fuhrman grade in pTlb renal cell carcinoma.
    Chen C; Kang Q; Wei Q; Xu B; Ye H; Wang T; Lu Y; Lu J
    Abdom Radiol (NY); 2017 May; 42(5):1464-1471. PubMed ID: 27999886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High expression of APRIL correlates with poor prognosis in clear cell renal cell carcinoma.
    Lee C; Park JW; Suh JH; Moon KC
    Pathol Res Pract; 2015 Nov; 211(11):824-8. PubMed ID: 26296917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. mTOR and mTOR phosphorylation status in primary and metastatic renal cell carcinoma tissue: differential expression and clinical relevance.
    Rausch S; Schollenberger D; Hennenlotter J; Stühler V; Kruck S; Stenzl A; Bedke J
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):153-163. PubMed ID: 30368665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.